Cure My Disease

Don't miss your cure!

 Log in / Sign up

Wearable sensors give Real-Time feedback to improve gait in children with hemiplegia

NCT ID NCT07683624

Disease control Sponsor: Cairo University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This trial tests whether a biofeedback system using wearable sensors can improve walking in children aged 7 to 12 with hemiplegia (weakness on one side). Participants wear sensors that provide real-time audio and visual cues while walking on a treadmill, helping them correct abnormal gait patterns. The study compares this approach to conventional physical therapy over three months, measuring changes in step time, stride length, and other walking parameters.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Steadys Biofeedback Gait Training System
What this could lead to
If effective, this approach could offer a more engaging and targeted way to improve walking patterns in children with hemiplegia, potentially enhancing mobility and independence.
What could go wrong
This is a small, early-stage trial with only 30 participants, so results may not apply to all children. The biofeedback system may not lead to significantly better outcomes than standard therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

7 to 12 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Their age will range from 7 to 12 years. * The degree of their spasticity will range from 1 to 1+ according to Modified Ashworth' Scale (Bohannon et al., 1987) (Appendix IⅠ). * They will be on level Ⅰ or Ⅱ on GMFCS (Palisano et al., 2007) (Appendix IⅡ). * They will be able to walk without the use of an assistive device * Children can follow instructions and understand given orders. Exclusion Criteria: * Severe visual or hearing impairment. * Fixed deformities or surgical interventions in the lower extremities. * Botulinum toxin injections in the last 6 months.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gait training are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cerebral palsy cerebral palsy spastic hemiplegic hemiplegia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Gait training Hemiplegic cerebral palsy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Faculty of Physical Therapy Cairo University

    Cairo, 11351, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.